BOSTON, Oct 16, 2002 -
PerkinElmer Life Sciences, a leading
provider of drug discovery, life science research and genetic disease
screening solutions, today announced the commercial availability of a
full range of clear SpectraPlate
microplates. The new range consists
of 96- and 384-well clear microplates in three different formats:
1) SpectraPlates with medium protein binding affinity (MB)
2) high protein binding affinity (HB)
3) tissue culture treated plates (TC) for adherent
cell culturing
The SpectraPlates are designed for use with
Enzyme Linked
Immuno-Sorbent Assays (ELISA) and other colorimetric assays.
Key features of the SpectraPlate microplates include:
* An innovative pinch bar design facilitates automated robotic
handling.
* Manufactured under strict clean room conditions to avoid dust and
other
contaminants.
* Very low intra-plate CV's and background readings ensure high
quality results.
* Increased nesting space and added bottom ribs that are guaranteed
compatible with PerkinElmer-supplied instrumentation.
* Unique design helps reduce instrument down time due to plate jams.
"These clear SpectraPlates complement PerkinElmer's wide range of
existing application-focused microplates," said Paul Gillyon, vice
president and general manager, Biomics and Research Products,
PerkinElmer Life Sciences. "This is one more example of how listening
to our customers' needs contributes to our ability to offer the latest
and most complete solutions in the industry."